Empagliflozin-Associated Pancreatitis: A Consideration for SGLT2 Inhibitors

被引：0
|
作者：
Dziadkowiec, Karolina [1 ]
Stawinski, Peter [1 ]
Proenza, Jose [1 ]
机构：
[1] Univ Miami, JFK Med Ctr Palm Beach, W Palm Beach, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1615
引用
收藏
页码：S726 / S727
页数：2
相关论文
共 50 条
  • [21] Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors
    Mederle, Alexandra Laura
    Dumitrescu, Patrick
    Borza, Claudia
    Kundnani, Nilima Rajpal
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [22] Development of SGLT1 and SGLT2 inhibitors
    Timo Rieg
    Volker Vallon
    Diabetologia, 2018, 61 : 2079 - 2086
  • [23] Development of SGLT1 and SGLT2 inhibitors
    Rieg, Timo
    Vallon, Volker
    DIABETOLOGIA, 2018, 61 (10) : 2079 - 2086
  • [24] SGLT2 inhibitor empagliflozin: finally at the latter stage of understanding?
    Chan, Gary C. W.
    Tang, Sydney C. W.
    KIDNEY INTERNATIONAL, 2018, 93 (01) : 22 - 24
  • [25] SGLT2 inhibitors for heart and kidney
    van der Giet, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1456 - 1461
  • [26] SGLT2 Inhibitors and Mechanisms of Hypertension
    Briasoulis, Alexandros
    Al Dhaybi, Omar
    Bakris, George L.
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (01)
  • [27] SGLT2 inhibitors in diabetes with CKD
    Malik, A. H.
    Yandrapalli, S.
    Goldberg, M.
    Jain, D.
    Frishman, W. H.
    Aronow, W. S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1448 - 1448
  • [28] SGLT2 Inhibitors: Mind the Gap
    Jiang, Chuan
    Palkar, Atul
    Caronia, Jonathan
    Gottesman, Eric
    CHEST, 2016, 150 (04) : 266A - 266A
  • [29] The expanding resume of SGLT2 inhibitors
    de Boer, Ian H.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (08): : 585 - 587
  • [30] SGLT2 inhibitors in clinical practice
    Ryden, Lars
    Norhammar, Anna
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (07): : 434 - 435
12345